Ionis (IONS) Expands Licensing Deal With Otsuka for HAE Drug
ZacksIonis (IONS) out-licenses the rights for its HAE drug to Otsuka in the Asia-Pacific region. The companies signed a similar deal last year granting Otsuka rights to market the drug in Europe.